4-Diethylamino-2-butyn-1-ol
Code | Size | Price |
---|
TAR-T0555-5mg | 5mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0555-10mg | 10mg | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0555-25mg | 25mg | £125.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0555-50mg | 50mg | £158.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0555-100mg | 100mg | £185.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0555-200mg | 200mg | £232.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
4-Diethylamino-2-butyn-1-ol is used as pharmaceutical intermediates.
CAS:
10575-25-4
Formula:
C8H15NO
Molecular Weight:
141.214
Purity:
0.98
SMILES:
CCN(CC)CC#CCO
References
1. Zorbist, R., Schmid, B., Feick, A., Quan, D., & Sanders, S. (2001). Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers.?Send To Pharm Res.,?18(1), 1029-34.
2. Chancellor, M. (2001). A comparison of the effects of saliva output of oxybutynin chloride and tolterodine tartrate.?Clinical Therapeutics,?23(5), 753-760. doi: 10.12016/s20149-2918(01)820024-2
3. Hughes, K., Lang, J., Lazare, R., Gordon, D., Stanton, S., Malone-Lee, J., & Geraint, M. (1992). Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers.?Xenobiotica,?22(7), 859-869. doi: 10.3109/200498259209053145